tradingkey.logo

Cosmos Health Inc

COSM
查看详细走势图
0.450USD
+0.010+2.23%
收盘 02/06, 16:00美东报价延迟15分钟
14.33M总市值
亏损市盈率 TTM

Cosmos Health Inc

0.450
+0.010+2.23%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.23%

5天

-6.43%

1月

-13.64%

6月

-57.19%

今年开始到现在

-9.74%

1年

-35.79%

查看详细走势图

TradingKey Cosmos Health Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Cosmos Health Inc当前公司基本面数据相对稳定,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在药品行业排名120/159位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价3.00。中期看,股价处于下降通道。近一个月,市场表现非常差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Cosmos Health Inc评分

相关信息

行业排名
120 / 159
全市场排名
417 / 4521
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Cosmos Health Inc亮点

亮点风险
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
业绩增长期
公司处于发展阶段,最新年度总收入54.43M美元
估值低估
公司最新PE估值-0.59,处于3年历史低位
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值235.74K
活跃度增加
近期活跃度增加,过去20天平均换手率0.15

分析师目标

根据 0 位分析师
--
评级
3.000
目标均价
+511.87%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Cosmos Health Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Cosmos Health Inc简介

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
公司代码COSM
公司Cosmos Health Inc
CEOSiokas (Grigorios)
网址https://www.cosmosholdingsinc.com/
KeyAI